AKT1 and non-small cell lung carcinoma: It has been confirmed that QYSLD can inhibit NSCLC by regulating the expression of PI3K/Akt/mTOR and Wnt/β-catenin signal transduction pathway molecules (Zhang and Li, 2017; Tong et al., 2018b).